Donald Trump conveyed the updated stance toward Tehran through a statement shared on his Truth Social platform. He contended that the opportunity to secure a negotiated settlement with the Iranian government has completely ended. To justify the position, Trump claimed the United States currently controls hundreds of billions of dollars belonging to Iran while maintaining hold over their strait.
Key points
The United States is no longer pursuing a formal diplomatic pact with the Iranian governm…: The United States is no longer pursuing a formal diplomatic pact with the Iranian government.
American leadership asserts that existing financial and maritime leverage removes the nec…: American leadership asserts that existing financial and maritime leverage removes the necessity for negotiations.
Diplomatic avenues are currently portrayed as closed due to the expiration of the negotia…: Diplomatic avenues are currently portrayed as closed due to the expiration of the negotiation window.
Sources checked by our analysis pipeline: 1
This is an entry from: Live: Nasser Hospital 'paralysed' after Israeli attack
Trump says US does not 'need a deal' with Iran
12 November 2026 14:08 GMT
US President Donald Trump has said that Washington does not "need a deal" with Iran, claiming "we've got their strait".
In a post to his Truth Social account, Trump said: “We don’t need a deal with Iran. Those days have long since passed. We have got their money, hundreds of billions of dollars and we’ve got their strait.”
Widespread Israeli bombardments across the Gaza Strip have inflicted fresh civilian casualties and further disrupted critical healthcare operations. The deadly strikes targeted vehicles and gatherings near medical hubs, compounding the destruction from an earlier attack on a major Khan Younis hospital. This continuous barrage intensifies the humanitarian emergency by severely degrading medical infrastructure and endangering personnel.
A decisive congressional sweep has reignited fierce internal debate over the Democratic Party's leadership and foreign policy stances regarding Israel. Grassroots activists and voters continue to scrutinize establishment leaders over past unconditional military aid, demanding accountability for years of Middle East policy decisions. However, top congressional incumbents retain crucial institutional support, complicating efforts by reformers to force an immediate ideological realignment.
Congressional scrutiny surrounds the potential confirmation of Heidi Overton to head the Food and Drug Administration. Lawmakers must navigate standard Senate procedures to determine whether she secures the leadership post. Her eventual path depends entirely on how these legislative processes unfold.